via The Scientist Magazine
- No vaccines exist for human coronavirus infections. A new intranasal vaccine using an RNA virus for gene delivery protects against fatal MERS coronavirus infections in mice.
- The mice were genetically engineered to be susceptible to the MERS virus. All the mice that received the vaccine survived MERS, while the mice that had not received the vaccine did not.
- The researchers are now applying the same strategy to develop a vaccine for SARS-CoV-2, the virus that causes COVID-19, which has infected more than a million people worldwide.
No vaccines exist that protect people against infections by coronaviruses, including SARS-CoV-2, which causes COVID-19, or the ones that cause SARS and MERS. As COVID-19 continues to wreak havoc, many labs around the world have developed a laser-like focus on understanding the virus and finding the best strategy for stopping it.
This week in mBio, a journal of the American Society of Microbiology, a team of interdisciplinary researchers describes a promising vaccine candidate against the MERS virus. Since the MERS (Middle East Respiratory Syndrome) outbreak began in 2012, more than 850 people have died, and studies suggest the virus has a case fatality rate of more than 30%.
In the new paper, the researchers suggest that the approach they took for a MERS virus vaccine may also work against SARS-CoV-2. The vaccine’s delivery method is an RNA virus called parainfluenza virus 5 (PIV5), which is believed to cause a condition known as kennel cough in dogs but appears harmless to people. The researchers added an extra gene to the virus so that infected cells would produce the S, or spike, glycoprotein known to be involved in MERS infections.
“We know people have been exposed to PIV5, but it seems to be an innocuous virus in humans,” said pediatric pulmonologist and coronavirus expert Paul McCray, M.D., at the University of Iowa, in Iowa City, who co-led the new study with virologist Biao He, Ph.D., at the University of Georgia, in Athens. “PIV5 doesn’t seem to cause a cytopathic effect.” The MERS virus cannot replicate in mice, so to test the vaccine McCray developed a mouse model that mimics human infections. The mice had been genetically engineered to express DPP4, the protein used by the MERS virus as an entry point for human cells.
Lab tests showed that a single dose of the vaccine, given intranasally, effectively caused infected cells to produce the S protein, which in turn triggered immune responses against the protein in the animal host.
Four weeks after the mice received the vaccine, they were exposed to a strain of the MERS virus, adapted to the mice to cause a lethal infection. The MERS virus was also given to groups of mice that had received a different PIV5 vaccine—one without the genes for the S protein—or an intramuscular vaccine with inactivated MERS virus.
All the mice immunized with the modified PIV5 virus survived MERS virus infection. In contrast, all the mice immunized with the PIV5 without S died from the infection. The intramuscular vaccine of inactivated MERS virus only protected 25% of the mice from a lethal infection. The mice that received inactivated MERS virus showed above-average levels of eosinophils, white blood cells that indicate infection or inflammation. This connection raises a safety concern for inactivated MERS virus as a potential vaccine, said He. The study demonstrates that an intranasal, PIV5-based vaccine is effective against MERS in mice, said He, and should be investigated for its potential against other dangerous coronaviruses, including SARS-CoV-2.
“We’re quite interested in using viruses as gene delivery vehicles,” said McCray, who has also investigated similar strategies as a way to treat cystic fibrosis. Now, like colleagues around the world, McCray and He have both focused their research efforts on SARS-CoV-2, taking a similar tack to working with mouse models of infection and testing vaccines.
Finding an effective vaccine against the coronavirus that causes COVID-19 is a race against time, McCray said. “One hundred percent of the population is not going to be exposed to the virus the first time around, which means there will be more people to infect when it comes again,” he said. “We don’t know yet if people get lasting immunity from the SARS-CoV-2 infection, so it’s important to think about ways to protect the population.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Blocking coronavirus infections
- Rehabilitation after COVID-19on October 7, 2020 at 2:41 am
For some patients who have had COVID-19, symptoms of the disease may last long after the infection is over ... after doing something as simple as doing the laundry or taking a one block walk.’ It’s ...
- Coronavirus reinfections are on the rise, and doctors can’t explain themon October 7, 2020 at 1:57 am
Doctors treating coronavirus patients have noticed an increasing number of COVID-19 reinfections. Scientists in various countries have reported reinfections, warning that the second bout of ...
- FDA releases coronavirus vaccine guidelines that Trump administration is trying to block, including 2-month safety reviewon October 6, 2020 at 11:15 am
The U.S. Food and Drug Administration wants coronavirus vaccine developers to follow trial patients for at least two months before seeking emergency approval, according to a newly released set of ...
- Coronavirus update: Trump returns from Walter Reed amid talk White House may block FDA on vaccineson October 6, 2020 at 10:13 am
President Donald Trump, fresh from a stint in the hospital after being diagnosed with COVID-19, re-ignited a political debate over a vaccine timeline, putting him at odds the U.S. Food and Drug ...
- White House signs off on FDA’s coronavirus vaccine guidelines after trying to block them: reporton October 6, 2020 at 8:56 am
Reluctant White House officials on Tuesday endorsed the U.S. Food and Drug Administration’s strict guidelines for approving a coronavirus vaccine, essentially confirming that a shot likely won’t get ...
Go deeper with Google Headlines on:
Blocking coronavirus infections
Go deeper with Bing News on:
- Humans can transmit Covid-19 virus to wildlife: Studyon October 7, 2020 at 2:15 am
The study, published in the journal Mammal Review, noted that if SARS-CoV-2 were to infect and spread among wild mammals, it could potentially cause disease in some populations, in turn further ...
- Durant schools face scheduling, other challenges as virus concerns loomon October 6, 2020 at 10:28 pm
It’s been a topsy-turvy start to an unprecedented school year for the Durant Independent School District.The latest hit was last week’s high ...
- Discovery of the Hepatitis C virus wins 2020 Nobel Prize for Physiology or Medicineon October 5, 2020 at 9:15 am
The prize was jointly awarded to three scientists whose work led to the development of medicines that saved millions of lives.
- Medicine Nobel prize goes to discoverers of hepatitis C viruson October 5, 2020 at 8:43 am
Harvey Alter, Michael Houghton and Charles Rice share prize for uncovering the disease-causing agent affecting more than 71 million people ...
- A Common Plant Virus Is an Unlikely Ally in the War on Canceron October 5, 2020 at 4:00 am
Researchers have seen promising results by injecting dog and mouse tumors with the cowpea mosaic virus. Now they’re aiming for a human trial.